Best allergy medications
Pro Research Analysisby 
Searched over 200M research papers
Best Allergy Medications: A Comprehensive Review
Introduction to Allergy Medications
Allergic rhinitis and other allergic conditions significantly impact the quality of life for many individuals. Effective management often requires a combination of medications and therapies. This article synthesizes the latest research on the best allergy medications, focusing on sublingual immunotherapy (SLIT), subcutaneous immunotherapy (SCIT), and biologics.
Sublingual Immunotherapy (SLIT) for Allergic Rhinitis
Efficacy and Safety of SLIT
Sublingual immunotherapy (SLIT) has gained attention as a safer alternative to traditional allergen injection immunotherapy. Research indicates that SLIT significantly reduces symptoms and medication requirements in patients with allergic rhinitis1 2. A meta-analysis of 22 trials involving 979 patients demonstrated a significant reduction in both symptoms (SMD -0.42) and medication use (SMD -0.43) following SLIT treatment1 2.
Comparison with Placebo
SLIT has been shown to be more effective than placebo in reducing symptoms and medication use for seasonal allergic rhinitis, particularly with grass allergens8. However, the benefit is modest, and the treatment is more efficacious in adults than in children8.
Subcutaneous Immunotherapy (SCIT) vs. SLIT
Comparative Effectiveness
Subcutaneous immunotherapy (SCIT) and SLIT are the two most prescribed routes for allergen-specific immunotherapy. A meta-analysis comparing these two methods found that SCIT is more effective than SLIT in controlling symptoms and reducing the use of antiallergic medications in patients with seasonal allergic rhinitis to grass pollen3. The overall effect size for SCIT in symptom score (SMD -0.92) was significantly higher than that for SLIT administered via drops (SMD -0.25) and tablets (SMD -0.40)3.
Safety Considerations
While SCIT is more effective, SLIT is preferred by many due to its improved safety profile and ease of administration3. SCIT carries a higher risk of severe systemic reactions, which limits its use1 2.
Biologics for Allergy and Asthma
Available Biologics
Biologics have emerged as a potent option for treating severe allergic conditions and asthma. Approved biologics include omalizumab, mepolizumab, reslizumab, benralizumab, and dupilumab7. These agents target specific pathways involved in allergic responses, offering a more tailored approach to treatment.
Therapeutic Effects and Safety
Biologics are generally effective and safe, but they come with high costs and complex dosing regimens7. They are particularly useful for patients who do not respond well to traditional treatments like antihistamines and corticosteroids9.
Allergen Immunotherapy (AIT) and Disease Modification
Long-term Benefits
Allergen immunotherapy (AIT), including both SCIT and SLIT, is the only treatment that can modify the course of allergic diseases. It has been shown to prevent the development of asthma and new allergen sensitizations6. A 3-year course of AIT can be recommended for children and adolescents with moderate-to-severe allergic rhinitis triggered by grass or birch pollen to prevent asthma for up to 2 years post-treatment5.
Mechanisms of Action
AIT works by inducing allergen-specific immune tolerance, involving regulatory cell subsets and suppressor cytokines like IL-10 and TGF-β4. This leads to a sustained reduction in allergy symptoms and medication requirements4.
Conclusion
In summary, the best allergy medications include SLIT and SCIT for their efficacy in reducing symptoms and medication use, with SCIT being more effective but SLIT offering a better safety profile. Biologics provide a valuable option for severe cases, although they are costly and complex to administer. Allergen immunotherapy remains the only treatment capable of modifying the disease course, offering long-term benefits and prevention of new sensitizations. Further research is needed to optimize these treatments and identify the most suitable candidates for each therapy.
Sources and full results
Most relevant research papers on this topic
Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis *
Sublingual immunotherapy significantly reduces symptoms and medication requirements in allergic rhinitis patients, but longer treatment duration does not clearly increase efficacy.
Meta-Analysis
Highly CitedSublingual immunotherapy for allergic rhinitis
Sublingual immunotherapy significantly reduces symptoms and medication requirements in allergic rhinitis patients, with no significant difference in effectiveness based on the allergen administered.
Meta-AnalysisHighly CitedEfficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison.
SCIT is more effective than SLIT in controlling symptoms and reducing antiallergic medication use in seasonal allergic rhinitis to grass pollen.
Meta-AnalysisHighly CitedMechanisms of allergen-specific immunotherapy and allergen tolerance.
Allergen-specific immunotherapy effectively treats allergic disorders, improving symptoms and reducing medication requirements, but requires customized treatment plans and improved safety measures.
Meta-AnalysisHighly CitedEAACI guidelines on allergen immunotherapy: Prevention of allergy
Allergen immunotherapy (AIT) can prevent asthma in children with grass/birch pollen allergy, but more high-quality clinical trials are needed for other allergic conditions and preventive effects.
Systematic Review
Rigorous JournalHighly CitedInternational consensus on allergy immunotherapy.
Allergen immunotherapy (AIT) is an effective and safe treatment for allergic diseases, but its use remains underused and needs a wider international consensus to improve safety and effectiveness.
Rigorous JournalHighly CitedStrategies for choosing a biologic for your patient with allergy or asthma.
Biotics for respiratory and allergic diseases are generally effective and safe, but their long-term effectiveness remains unclear due to a lack of adequate biomarkers and disease severity.
Systematic ReviewEfficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis.
Sublingual immunotherapy with grass allergens effectively reduces symptoms and medication use in patients with seasonal allergic rhinitis compared to placebo, with more efficacy in adults than children.
Meta-AnalysisRigorous JournalHighly CitedDrug repurposing to treat asthma and allergic disorders: Progress and prospects
Drug repurposing could provide new, cheap, and convenient treatment options for asthma and allergy patients by repositioning effective and safe small-molecule drugs from other fields of medicine.
Rigorous Journal